Apollo (APO) Q3 2026 Earnings Call Transcript

Apollo reported Q3 2026 record fee-related earnings of $802 million, up 23% year over year, and adjusted net income of $1.3 billion, or $2.07 per share. Management expects 2027 fee-related earnings growth of 20% or more and management fee growth of at least 15%, while Athene spread-related earnings were $909 million excluding notable items, up 9% year over year. Apollo plans about $350 million in data and technology investment over the next 24 months to support private-asset pricing, trading, custody and settlement; executives also cited a $65 million unfavorable actuarial review impact and warned of possible regulatory changes for insurers using nonreciprocal offshore jurisdictions.

Analysis

APO’s upside is increasingly tied to origination and distribution economics, not simply asset growth: scaled deal flow can support recurring fees, but revenue recognition and deployment timing make quarterly ACS fees lumpy. The $350 million technology program is a near-term expense with uncertain payback; the strategic option is whether daily valuation, identifiers and secondary trading expand the buyer base and create new service revenues. Greater transparency is double-edged: it may ease allocations, but also make private-credit marks more visibly sensitive to public spreads and expose liquidity mismatches in semi-liquid vehicles.

The potential 2027 insurance-capital changes could improve Athene’s relative pricing if they constrain nonreciprocal-jurisdiction arbitrage. That remains a regulatory catalyst, not a realized earnings benefit; scope, transition rules and implementation matter. Meanwhile, AI infrastructure lending may generate fee opportunities, but security, amortization and guarantees do not eliminate correlated exposure to the same capex cycle or guarantors. A slowdown in data-center investment or weaker refinancing markets could impair both origination and collateral values.

Near term, strong operating results support sentiment, but without valuation, current price action or consensus data, they do not establish upside from here. Over 1–3 months, verify fee conversion, expense trajectory and 2027 guidance detail. Over 6–18 months, the key test is whether liquidity infrastructure attracts durable third-party capital without increasing redemption or mark volatility. Thesis weakens if management-fee growth decelerates, FRE margins compress materially, or regulatory action fails to narrow capital differences.

Key Decisions for Investors

• APO: Treat as a conditional long-on-pullbacks, not a chase after earnings. Reassess against the actual share-price reaction and valuation; require continued management-fee growth and conversion of signed originations into fees. Reduce or exit if growth guidance is cut or expense investment drives sustained margin compression.
• Track NAIC implementation into 2027 as a relative catalyst for Athene, not a base-case earnings uplift yet. Verify which jurisdictions, products and new-versus-existing contracts are covered; if rules are delayed or permit equivalent capital arbitrage, remove the prospective benefit from the thesis.
• Keep AI-linked credit exposure selective: favor structures with enforceable senior security, amortization and credible guarantees over residual-value-dependent lending. For APO, monitor concentration and deal terms; a capex slowdown, weakening guarantor credit or deterioration in refinancing conditions would falsify the benign financing thesis.
• MFIC/ARCC: Avoid a standalone relative-value trade until the definitive exchange ratio, cash component, closing conditions and post-deal economics are verified. The announced premium may already be reflected in MFIC, while the impact on ARCC depends on consideration and dilution.